New Philips Cadmium Selenide-Based Quantum Dot Monitors Represent Major Breakthrough for EU in Competitiveness, Environmental Protection and Energy Efficiency
6.10.2015 06:00 | Business Wire
The recent introduction of Philips’ long-awaited 276E6ADSW monitor in the EU market represents a major display technology breakthrough. Relying on revolutionary quantum dot technology developed by QD Vision, which is more energy efficient than alternative color conversion technologies currently available, the new monitors offer far superior color performance than those available with such alternative technologies, and at very competitive prices. Wide color gamut technology is considered essential for companies to remain competitive in important technical fields ranging from medical diagnostics to e-commerce, while providing a major boost in energy efficiency. At the same time, QD Vision’s quantum dot technology is friendlier to the environment than the indium-based or “cadmium-free” quantum dots technology being pursued by other companies.
QD Vision is responding to a statement issued yesterday as part of an ongoing public relations campaign by Nanoco to have cadmium selenide-based quantum dots excluded from the EU market despite statements by both Parliament and the Commission that Exemption 39 remains valid at this time. Nanoco continues its efforts to have products using its indium-based quantum dot technology introduced into the EU display market, but there are none to date. In the first quarter of this year, Samsung introduced televisions based on indium phosphide in the European market.
In May of this year, the European Parliament asked the European Commission to review a recent decision to extend QD Vision’s exemption for using cadmium selenide based on its solution’s energy efficiency and a lack of competitive alternatives. According to the Commission, that review is underway according to the process prescribed by the Parliament, which also stated that, in the meantime, their recommendation should introduce “no market disruptions.” Claims by Nanoco that the exemption was stopped by the Commission and Parliament are incorrect and misleading.
"We look forward to a swift technical assessment of the alternatives in this exciting segment – one that will plainly demonstrate that safe and energy-efficient cadmium selenide quantum dots are the only competitive solution for Europe," said Mustafa Ozgen, CEO of QD Vision. "I don’t think any potential competitor intentionally attempted to mislead the European Parliament by their filings, but they seem to be unfamiliar with the significant advantages of the cadmium selenide-based quantum dots product in color, energy efficiency and environmental friendliness and the inability of alternative products to match these important performance characteristics.”
The Philips monitor is the first quantum dot based monitor in the market today. There is currently no monitor in the market using indium quantum dots. Televisions based on QD Vision’s quantum dot technology have been on the market since 2013.
About QD Vision, Inc.
QD Vision, Inc. is a leader in quantum dot display technology for QLED displays. Quantum dot technology is a superior next-generation alternative to OLED displays, providing unparalleled color representation at a highly competitive LCD cost structure. Color IQ quantum dot technology from QD Vision provides a unique optical component solution capable of delivering “full-gamut” color to the display industry. Founded in 2004, the company has raised more than $100 million in financing from top-tier venture capital firms and is headquartered in Lexington, Massachusetts. http://www.coloriq.com
COLOR IQ, QLED, and QD VISION are trademarks of QD Vision, Inc. The COLOR IQ and QD VISION trademarks are registered in one or more countries.
For QD Vision:
Michele Dempsey, 781-652-7525
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Altierre Strengthens Executive Team in Europe With Hiring of Guillaume Vicot and Niclas Qvist22.8.2017 12:00 | Pressemelding
Altierre Corp., a provider of the world’s highest density, ultra-low energy, long-range wireless technology and applications for the Internet of Things (IoT) market, today announced two additions to its France-based European executive team. Guillaume Vicot has joined the company as General manager, Europe, Middle East and Asia (EMEA) and Niclas Qvist has joined as Vice President, Partner management & Marketing. Vicot joins Altierre’s management team after 17 successful years in the Auto-ID industry, barcode scanning and mobile computing. He most recently served as Vice President of sales, Western Europe, for PSC / Datalogic, leader in the bar code scanning industry, where he oversaw a team of more than 100 people and developed a tactical go-to-market strategy, achieving revenue well over US$100 million. “Guillaume has many top level strategic relationships with retailers
IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11 | Pressemelding
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25 | Pressemelding
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00 | Pressemelding
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03 | Pressemelding
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom